Title |
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
|
---|---|
Published in |
medRxiv, January 2022
|
DOI | 10.1101/2022.01.25.22269794 |
Authors |
Venice Servellita, Abdullah M. Syed, Noah Brazer, Prachi Saldhi, Miguel Garcia-Knight, Bharath Sreekumar, Mir M. Khalid, Alison Ciling, Pei-Yi Chen, G. Renuka Kumar, Amelia S. Gliwa, Jenny Nguyen, Alicia Sotomayor-Gonzalez, Yueyuan Zhang, Edwin Frias, John Prostko, John Hackett, Raul Andino, Jennifer Doudna, Melanie Ott, Charles Y. Chiu |
X Demographics
The data shown below were collected from the profiles of 7,633 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 689 | 9% |
United States | 499 | 7% |
Thailand | 378 | 5% |
Canada | 185 | 2% |
United Kingdom | 139 | 2% |
Austria | 109 | 1% |
Switzerland | 74 | <1% |
France | 70 | <1% |
Netherlands | 65 | <1% |
Other | 611 | 8% |
Unknown | 4814 | 63% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 7123 | 93% |
Scientists | 254 | 3% |
Practitioners (doctors, other healthcare professionals) | 166 | 2% |
Science communicators (journalists, bloggers, editors) | 90 | 1% |